| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 17.15▼ | 17.80▼ |
| MA10 | N/A | N/A | N/A | 17.48▼ | 16.00▲ |
| MA20 | N/A | N/A | N/A | 17.85▼ | 14.22▲ |
| MA50 | N/A | N/A | N/A | 15.70▲ | 12.15▲ |
| MA100 | N/A | N/A | N/A | 14.01▲ | 12.53▲ |
| MA200 | N/A | N/A | N/A | 12.31▲ | 19.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | -0.310▼ | 0.306▲ |
| RSI | N/A | N/A | N/A | 45.220▼ | 56.769▲ |
| STOCH | N/A | N/A | N/A | 31.134 | 63.657 |
| WILL %R | N/A | N/A | N/A | -95.455▼ | -50.000 |
| CCI | N/A | N/A | N/A | -131.259▼ | 55.681 |
|
Wednesday, September 23, 2020 03:36 PM
And Allergy Therapeutics' (LON:AGY) reported sales growth in their full year results - there is an interview on proactiveinvestors.co.uk right and plenty more.
|
|
Wednesday, September 23, 2020 05:01 AM
Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020. The British biotechnology company's annual profit jumps to £8 million.
|
|
Wednesday, September 23, 2020 04:26 AM
Allergy Therapeutics PLC (LON:AGY) said profits rose in the year to end June 2020, as sales in Germany and elsewhere in Europe stayed strong despite coronavirus disruption. Net profits jumped to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/09/20 | 17.25 | 17.25 | 16.00 | 16.25 | 398,281 |
| 23/09/20 | 17.95 | 17.98 | 17.00 | 17.25 | 571,340 |
| 22/09/20 | 17.00 | 17.625 | 16.50 | 17.25 | 98,809 |
| 21/09/20 | 17.50 | 17.50 | 16.50 | 17.25 | 109,148 |
| 18/09/20 | 17.75 | 18.3875 | 17.50 | 17.75 | 252,365 |
| 17/09/20 | 18.50 | 18.50 | 17.7575 | 18.125 | 136,100 |
| 16/09/20 | 18.15 | 18.40 | 17.68 | 18.125 | 89,181 |
| 15/09/20 | 18.20 | 18.20 | 17.68 | 18.00 | 46,384 |
| 14/09/20 | 16.50 | 18.25 | 16.50 | 18.00 | 525,908 |
| 11/09/20 | 17.25 | 17.25 | 16.50 | 16.75 | 229,144 |
|
|
||||
|
|
||||
|
|